GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $222,000 | 0.0% | 5,097 | 0.0% | 0.02% | +13.3% |
| Q1 2022 | $222,000 | -8.3% | 5,097 | -7.3% | 0.02% | -6.2% |
| Q4 2021 | $242,000 | +15.2% | 5,497 | 0.0% | 0.02% | +6.7% |
| Q3 2021 | $210,000 | -2.3% | 5,497 | +1.9% | 0.02% | 0.0% |
| Q2 2021 | $215,000 | +2.4% | 5,397 | -8.5% | 0.02% | -6.2% |
| Q1 2021 | $210,000 | -7.5% | 5,897 | -4.5% | 0.02% | -15.8% |
| Q4 2020 | $227,000 | -2.6% | 6,177 | 0.0% | 0.02% | -13.6% |
| Q3 2020 | $233,000 | -7.5% | 6,177 | 0.0% | 0.02% | -15.4% |
| Q2 2020 | $252,000 | +17.2% | 6,177 | +8.8% | 0.03% | 0.0% |
| Q1 2020 | $215,000 | -11.5% | 5,677 | +9.7% | 0.03% | +8.3% |
| Q4 2019 | $243,000 | +10.0% | 5,177 | 0.0% | 0.02% | +4.3% |
| Q3 2019 | $221,000 | 0.0% | 5,177 | -6.3% | 0.02% | 0.0% |
| Q2 2019 | $221,000 | -4.3% | 5,527 | 0.0% | 0.02% | -11.5% |
| Q1 2019 | $231,000 | +3.1% | 5,527 | -5.6% | 0.03% | -7.1% |
| Q4 2018 | $224,000 | +4.2% | 5,852 | +9.3% | 0.03% | +21.7% |
| Q3 2018 | $215,000 | -2.7% | 5,352 | -2.5% | 0.02% | -8.0% |
| Q2 2018 | $221,000 | +2.8% | 5,492 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $215,000 | -35.4% | 5,492 | -33.0% | 0.02% | -37.5% |
| Q3 2017 | $333,000 | -5.7% | 8,192 | 0.0% | 0.04% | -4.8% |
| Q2 2017 | $353,000 | +2.3% | 8,192 | 0.0% | 0.04% | 0.0% |
| Q1 2017 | $345,000 | +9.5% | 8,192 | 0.0% | 0.04% | +2.4% |
| Q4 2016 | $315,000 | -10.8% | 8,192 | 0.0% | 0.04% | -8.9% |
| Q3 2016 | $353,000 | -0.6% | 8,192 | 0.0% | 0.04% | -6.2% |
| Q2 2016 | $355,000 | +6.9% | 8,192 | 0.0% | 0.05% | +4.3% |
| Q1 2016 | $332,000 | -37.6% | 8,192 | -37.9% | 0.05% | -38.7% |
| Q4 2015 | $532,000 | +6.2% | 13,192 | +1.2% | 0.08% | +2.7% |
| Q3 2015 | $501,000 | -4.6% | 13,042 | +3.3% | 0.07% | +4.3% |
| Q2 2015 | $525,000 | +86.2% | 12,622 | +106.2% | 0.07% | +84.2% |
| Q1 2015 | $282,000 | +35.6% | 6,122 | +25.7% | 0.04% | +35.7% |
| Q4 2014 | $208,000 | -13.7% | 4,872 | -7.1% | 0.03% | -17.6% |
| Q3 2014 | $241,000 | -13.9% | 5,247 | 0.0% | 0.03% | -8.1% |
| Q2 2014 | $280,000 | 0.0% | 5,247 | 0.0% | 0.04% | -7.5% |
| Q1 2014 | $280,000 | 0.0% | 5,247 | 0.0% | 0.04% | -2.4% |
| Q4 2013 | $280,000 | +14.8% | 5,247 | +7.7% | 0.04% | +5.1% |
| Q3 2013 | $244,000 | +0.4% | 4,872 | 0.0% | 0.04% | -2.5% |
| Q2 2013 | $243,000 | – | 4,872 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |